PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,934 | -36.0% | 16,303 | +5.9% | 0.00% | 0.0% |
| Q2 2023 | $425,155 | +63.3% | 15,393 | +35.9% | 0.00% | 0.0% |
| Q1 2023 | $260,429 | +110.8% | 11,323 | 0.0% | 0.00% | – |
| Q4 2022 | $123,534 | +34.3% | 11,323 | +3.3% | 0.00% | – |
| Q3 2022 | $92,000 | +5.7% | 10,963 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -66.4% | 10,963 | +0.1% | 0.00% | -100.0% |
| Q1 2022 | $259,000 | -30.9% | 10,953 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $375,000 | +95.3% | 10,953 | +1.2% | 0.00% | – |
| Q3 2021 | $192,000 | -59.1% | 10,828 | +3.6% | 0.00% | -100.0% |
| Q2 2021 | $469,000 | +109.4% | 10,448 | +21.1% | 0.00% | – |
| Q1 2021 | $224,000 | – | 8,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |